Recent developments with novel systemic drugs, palliative surgical techniques and diagnostic imaging have given hope for the treatment of patients whose breast cancer has spread beyond its primary tumour. Written by a team from leading cancer centers in Europe, including the UK's Royal Marsden Hospital, the Handbook of Metastatic Breast Cancer, Second Edition provides advanced scientific information and guidance on clinical problems associated with metastatic breast cancer.
The author, herself a metastatic breast cancer patient, created this book to help patients and their loved ones cope with a complex and difficult disease. The Insider's Guide to Metastatic Breast Cancer provides information about approved therapies in the U.S., Canada, Europe, and Australia, as well as scientific studies, cutting edge research, clinical trials, and palliative care.The adage that "knowledge is power" is particularly compelling when dealing with issues affecting survival and quality of life. Consequently, this fact-based handbook is a must-read for every patient contending with treatment decisions and side effects.
From the medical leaders of 27 leading cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to Metastatic Breast Cancer. Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources. Each patient-friendly chapter prepares patients and caregivers to talk with their doctors and make treatment decisions. Let this authoritative handbook be your guide! Part 1: Breast cancer basics - Explains breast cancer and staging. Part 2: Treatment planning - Describes how doctors plan treatment. Part 3: Treatment guide - Presents treatment options based on the features of the cancer. Part 4: Making treatment decisions - Offers tips for choosing the best treatment. A complete glossary with dictionary and acronyms completes this book.
Designed for quick, everyday reference, Handbook of Targeted Cancer Therapy and Immunotherapy: Breast Cancer provides a practical overview of this rapidly advancing field. Comprehensive yet concise, this easy-access resource by Drs. Senthil Damodaran and Debu Tripathy of MD Anderson Cancer Center helps you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and clinical performance of approved or investigational targeted agents and combinations of agents.
Author: National Comprehensive Cancer Network® (NCCN®)
Publisher:
ISBN: 1945835885
Category:
Page:
View: 314
[OFFICIAL CURRENT VERSION] From the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to Metastatic Breast Cancer. Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients help patients and caregivers talk with their doctors and make treatment decisions. Topics include breast cancer basics, tests for metastatic breast cancer, treatment options, hormone positive with HER2-, hormone positive with HER2+, hormone negative with HER2+, triple-negative breast cancer, and making treatment decisions. Let this authoritative handbook be your guide!
Skeel's Handbook of Cancer Chemotherapy combines in one place the most current rationale and specific details necessary to safely administer chemotherapy for most adult cancers. The handbook is a practical, diseased-focused pocket reference that emphasizes the best current medical practice as it relates to the delivery of chemotherapeutic drugs. By focusing on specific plans for treatment, the book is an invaluable resource for the daily care of cancer patients.
Handbook of Breast Cancer and related Breast Disease is a practical guide to the management of patients with breast malignancies and related non-neoplastic lesions. Written and edited by leading experts, this handbook focuses on the application of conventional and novel treatment strategies to the care of patients with nonmalignant breast disease and all stages of breast cancer. The handbook is organized chronologically, from screening, through diagnosis and management, to survivorship care and related medical issues. The bulk of these chapters provide evidence-based treatment strategies for all patient subsets, including how to manage patients with high risk breast lesions, invasive breast carcinoma at each stage, and with all known molecular subtypes of breast cancer. Surgical, radiation, and medical treatment options are all discussed for each stage of breast cancer including treatment approaches in pregnancy and for high risk lesions and Phyllodes. This handbook is a comprehensive yet concise resource for residents, fellows, and early-career practitioners. Community oncologists, breast surgeons, radiation oncologists, primary care practitioners, and OBGYNs will also find its concise review of new research and procedures to be very useful in this dynamic field of medicine. Key Features: Includes discussion of genomic testing in management of early stage breast cancer Covers adjuvant and neoadjuvant treatment approaches Includes short clinical trial reviews for quick update of study endpoints and results for reference in management of breast cancer Outlines strategies for survivorship issues Key points in each chapter highlight clinical pearls and summarize other important concepts
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total new cancer cases each year. Of these cases, approximately 15–25% overexpress HER2, a transmembrane RTK kinase that is associated with aggressive tumor growth and poor outcomes. However, in the past decade, survival rates of patients with HER-positive breast cancer have significantly improved due to increased screening, HER2 testing, and breakthrough HER2-targeted drug therapies. Handbook of HER2-Targeted Agents in Breast Cancer provides oncologists, primary care physicians, trainees and other healthcare providers with a concise, accessible, and up-to-date survey of the field, including a review of our current understanding of the biology of the HER2 pathway and the rationale for targeting it in early-stage and advanced breast cancer, an overview of HER2-testing, and evidence-based discussions of available HER2-targeted regimens in the adjuvant and metastatic settings.
This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.
Designed for quick reference, this handbook provides easily accessible information on the specific drugs and treatment regimens used in cancer chemotherapy. This updated Second Edition includes new drugs and combinations of drugs and reflects the increasing use of chemotherapy in combination with radiation and surgery. The first section presents site-specific cancer staging tables, treatment recommendations, and combination chemotherapy regimens and includes chapters on toxicity grading, dose modifications, and precautions. The second section alphabetically lists all current chemotherapeutic agents and provides essential information on each drug, including interactions, toxicity, indications, and dosing. The third section focuses on control of side effects. This edition is also available electronically for handheld computers. See Media listing for details.
This Essential Book Provides On-The-Spot Clinical Guidelines For Assessing And Advising Patients On Their Risk Of Breast Cancer, Therapeutic Options, And Other Issues Of Critical Importance To Women Concerned About Their Breast Health. In Highly-Condensed, Outline Format, The Handbook Provides Extensive, Authoritative, And Current Recommendations On Such Critical Issues As Hormone Replacement Therapy, Chemoprevention, Lifestyle Factors, Genetic Counseling, Imaging Of High-Risk Patients, Economic Factors, And Much More.
